production antimalarial drug precursor artemisinic acid engineered yeast 
malaria global health problem threatens - million people kills one million people annually1 disease control hampered occurrence multi-drug-resistant strains malaria parasite plasmodium falciparum23 synthetic antimalarial drugs malarial vaccines currently developed efficacy malaria awaits rigorous clinical testing45 artemisinin sesquiterpene lactone endoperoxide extracted artemisia annua l family asteraceae; commonly known sweet wormwood highly effective multi-drug-resistant plasmodium spp short supply unaffordable malaria sufferers6 although total synthesis artemisinin difficult costly7 semi-synthesis artemisinin derivative microbially sourced artemisinic acid immediate precursor cost-effective environmentally friendly high-quality reliable source artemisinin89 report engineering saccharomyces cerevisiae produce high titres mg l- artemisinic acid using engineered mevalonate pathway amorphadiene synthase novel cytochrome p450 monooxygenase cyp71av1 annua performs three-step oxidation amorpha--diene artemisinic acid synthesized artemisinic acid transported retained outside engineered yeast meaning simple inexpensive purification process can used obtain desired product although engineered yeast already capable producing artemisinic acid significantly higher specific productivity annua yield optimization industrial scale-up will required raise artemisinic acid production level high enough reduce artemisinin combination therapies significantly current prices 
